Hostname: page-component-89b8bd64d-ktprf Total loading time: 0 Render date: 2026-05-07T20:26:49.666Z Has data issue: false hasContentIssue false

Decades of cholera in Odisha, India (1993–2015): lessons learned and the ways forward

Published online by Cambridge University Press:  07 June 2021

Hemant Kumar Khuntia
Affiliation:
ICMR-Regional Medical Research Centre, Chandrasekharpur, Bhubaneswar, Odisha, India
Thandavarayan Ramamurthy
Affiliation:
ICMR-National Institute of Cholera and Enteric Diseases, P-33, CIT Road, Scheme XM, Beleghata, Kolkata, 700010, India
Madhusmita Bal
Affiliation:
ICMR-Regional Medical Research Centre, Chandrasekharpur, Bhubaneswar, Odisha, India
Sanghamitra Pati
Affiliation:
ICMR-Regional Medical Research Centre, Chandrasekharpur, Bhubaneswar, Odisha, India
Manoranjan Ranjit*
Affiliation:
ICMR-Regional Medical Research Centre, Chandrasekharpur, Bhubaneswar, Odisha, India
*
Author for correspondence: Manoranjan Ranjit, Email: ranjit62@gmail.com
Rights & Permissions [Opens in a new window]

Abstract

Cholera is one of the major public health problems in the state of Odisha, India since centuries. The current paper is a comprehensive report on epidemiology of cholera in Odisha, which was documented from 1993. PubMed and Web of Knowledge were searched for publications reporting cholera in Odisha during the period 1993–2015. The search was performed using the keywords ‘Odisha’ and/or ‘Orissa’ and ‘Cholera’. In addition, manual search was undertaken to find out relevant papers. During the study period, a total of 37 cholera outbreaks were reported with an average of >1.5 cholera outbreaks per year and case fatality ratio was 0.3%. Vibrio cholerae O1 Ogawa serotype was the major causative agent in most of the cholera cases. The recent studies demonstrated the prevalence of V. cholerae O1, El Tor variants carrying ctxB1, ctxB7 and Haitian variant tcpA allele associated with polymyxin B sensitivity and these variants are replacing the proto type El Tor. The first report of variant ctxB7 in Odisha during super-cyclone 1999 predicted its emergence and subsequent spread causing cholera outbreaks. The prevalence of multidrug-resistant V. cholerae at different time periods created alarming situation. The efficacy trial of oral cholera vaccine (OCV, Shanchol) in a public health set-up in Odisha has shown encouraging results which should be deployed for community level vaccination among the vulnerable population. This paper has taken an effort to disseminate the valuable information of epidemiology of cholera that will influence the policy-makers and epidemiologists for constant surveillance in other parts of Odisha, India and around the globe.

Information

Type
Original Paper
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © The Author(s), 2021. Published by Cambridge University Press
Figure 0

Fig. 1. Distribution of cholera cases and outbreaks in Odisha, 1993–2015.

Figure 1

Table 1. Outbreaks, cholera cases and deaths from 1993 to 2014 in Odisha

Figure 2

Fig. 2. Cholera outbreak districts. ★ Indicates cholera outbreaks ≥2; ▴ indicates one cholera outbreak.

Figure 3

Fig. 3. Yearly reported number of cholera cases, by V. cholerae O1 and O139 during 1993–2015 in Odisha. VCE, V. cholerae O1, El tor biotype VCE; B1, V. cholerae O1, El tor biotype with ctxB1; VCEB7, V. cholerae O1, El tor biotype with ctxB7.

Figure 4

Fig. 4. Antibiogram profile of V. cholerae O1 during 1993–2015 in Odisha. A, ampicillin; G, gentamycin; N, neomycin; Na, nalidixic acid; S, streptomycin; Co, co-trimoxazole; C, chloramphenicol; T, tetracycline; E, erythromycin; Fz, furazolidone; Nx, norfloxacin; Cf, ciprofloxacin; Of, ofloxacin; At, azithromycin; Do, doxycyclin. Numbers inside each box indicates the percentage of drug resistance.